These opioids have been used in research, and also are being used for drug abuse. Isotonitazine has been implicated in opioid overdose deaths in Europe, Canada, and the United States beginning in 2019.
↑Ujváry I, Christie R, Evans-Brown M, Gallegos A, Jorge R, de Morais J, Sedefov R (April 2021). "DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles". ACS Chemical Neuroscience. 12 (7): 1072–1092. doi:10.1021/acschemneuro.1c00037. PMID33760580. S2CID232356192.
↑Montanari E, Madeo G, Pichini S, Busardò FP, Carlier J (August 2022). "Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review". Therapeutic Drug Monitoring. 44 (4): 494–510. doi:10.1097/FTD.0000000000000970. PMID35149665. S2CID246776288.
↑USpatent 2935514,Karl Hoffman&Alfred Hunger,"BENZiMiDAZOLES",published 1960-05-03, assigned to Ciba Pharmaceutical Products Inc.
↑Vandeputte MM, Verougstraete N, Walther D, Glatfelter GC, Malfliet J, Baumann MH, Verstraete AG, Stove CP. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass. Arch Toxicol. 2022 Jun;96(6):1865-1880. doi:10.1007/s00204-022-03294-2PubMed